Uroselective alpha-blockade for benign prostatic hyperplasia: Clinically significant or marketing savvy? Editorial

S. A. Kaplan

Research output: Contribution to journal › Editorial

7 Scopus citations

Access to Document

@article{dfd5770fd8be41b09effa81d08ecdb36,

title = "Uroselective alpha-blockade for benign prostatic hyperplasia: Clinically significant or marketing savvy? Editorial",

author = "Kaplan, {S. A.}",

year = "1999",

doi = "10.1016/S0090-4295(99)00326-X",

language = "English",

volume = "54",

pages = "776--779",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Uroselective alpha-blockade for benign prostatic hyperplasia

T2 - Clinically significant or marketing savvy? Editorial

AU - Kaplan, S. A.

PY - 1999

Y1 - 1999

UR - http://www.scopus.com/inward/record.url?scp=0032745129&partnerID=8YFLogxK

U2 - 10.1016/S0090-4295(99)00326-X

DO - 10.1016/S0090-4295(99)00326-X

M3 - Editorial

C2 - 10565732

AN - SCOPUS:0032745129

SN - 0090-4295

VL - 54

SP - 776

EP - 779

JO - Urology

JF - Urology

IS - 5

ER -